The global anemia treatment market was valued at USD 10.0 billion in 2022 and is expected to grow to USD 14.9 billion by 2028 ...

Disc Medicine, Inc. (NASDAQ:IRON), a biotechnology company focused on developing treatments for rare blood disorders, has ...

DelveInsight’s ‘Chemotherapy Induced Anemia Market Insights, Epidemiology, and Market Forecast – 2032’ report delivers an ...

In this review on the treatment of chronic anemia, the causes of chronic anemia that are of major public health importance in developing countries are discussed. These include nutritional ...

Valleant’s recently released guide aims to help individuals better understand anemia, explore treatment options, and offer nutritional and lifestyle advice to support the management of ...

New data from a Phase 1b clinical trial testing Fulcrum's pociredir for sickle cell disease are expected by the middle and ...

Ten days of subcutaneous Dacogen resulted in responses among a third of patients with myelofibrosis. Among patients with ...

This study documents that anemia occurs relatively frequently in COPD patients and is related to the presence of inflammation. Anemia is an understudied issue in COPD but may be of great ...

Since the first description of aplastic anemia in 1888 by Ehrlich, 1 both its diagnostic criteria and the therapeutic attempts at controlling it have been multiple and variable. Clinically ...

Panelists discuss key learnings from recent studies on lower-risk myelodysplastic syndrome (LR-MDS) treatment, identify ...